Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





ISOPROPYL ACETATE								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 108-21-4; **Chemical Formula:** CH3COOCH(CH3)2
OSHA previously had a 250-ppm 8-hour TWA limit for isopropyl acetate. The Agency proposed supplementing this limit with a 15-minute STEL of 310 ppm, based on the ACGIH (1986/Ex. 1-3) recommendation. OSHA is establishing these limits for this substance in the final rule. Isopropyl acetate is a colorless liquid and has a fruity odor.
The oral LD(50) for rats is reported to be 6.75 g/kg; five of six rats died after a four-hour exposure to 32,000 ppm, and one of six rats died after a four-hour exposure to 16,000 ppm (Smyth, Carpenter, Weil, and Pozzani 1954/Ex. 1-440).
The primary problems in occupational exposures to isopropyl acetate are eye and mucous membrane irritation. In humans, exposure to 200 ppm isopropyl acetate for 15 minutes caused eye irritation, with nose and throat irritation occurring at higher concentrations (Silverman, Schulte, and First 1946/Ex. 1-142). NIOSH (Ex. 8-47, Table N2) notes that the majority of subjects exposed to 200 ppm in the Silverman, Schulte, and First (1946/ Ex. 1-142) study experienced eye irritation and that the authors of this study recommended an 8-hour TWA of 100 ppm to prevent sensory irritation. OSHA agrees with NIOSH that this substance presents a hazard at elevated short-term levels and has accordingly added a STEL to ensure that worker exposures are maintained under good industrial hygiene control.
OSHA concludes that, in the absence of a short-term limit on exposure, the 250-ppm TWA limit alone will not protect employees from experiencing the irritant effects associated with elevated short-term exposures to isporopyl acetate. OSHA has determined that the irritant effects related to exposure to isopropyl acetate are material impairments of health. Therefore, to reduce the risk of irritation among exposed employees, the Agency is establishing a 250-ppm 8-hour TWA limit and a 310 ppm STEL for this substance.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue